| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 116,662 | 113,478 | 108,924 | 125,923 | | Cost of Revenue | 41,326 | 40,904 | 39,958 | 42,536 | | | Gross Profit | 75,336 | 72,574 | 68,966 | 83,387 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 24,775 | 25,840 | 25,686 | 32,971 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 14,585 | 14,037 | 13,584 | 14,111 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 35,976 | 32,697 | 29,696 | 36,305 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7) | 900 | 475 | 455 | | Earnings Before Interest And Taxes | 35,969 | 33,597 | 30,171 | 36,760 | | Interest Expense | 7,059 | 7,495 | 7,356 | 8,929 | | Income Before Tax | 28,910 | 26,102 | 22,815 | 27,831 | | Income Tax Expense | 11,338 | 9,624 | 6,783 | 10,579 | | Minority Interest | 172 | 53 |
-
|
-
| | | | Net Income From Continuing Ops | 17,744 | 16,531 | 16,032 | 17,252 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 17,744 | 16,531 | 16,032 | 17,252 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $17,744 | $16,531 | $16,032 | $17,252 |
|
0.20% Nasdaq 
Income Statement
